Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis
Conclusions:
The 2-year results indicate that there is a place for the Boston type 1 KPro in the management of corneal blindness. However, there is scarce evidence regarding its medium- and long-term efficacy and safety. The high rate of reported complications necessitates strict patient selection and stringent follow-up.
Source: Cornea - Category: Opthalmology Tags: Review Source Type: research
More News: Blindness | Corneal Transplant | Databases & Libraries | Eyes | Glaucoma | Opthalmology | Study